zurück zur Startseite
Zentrale Tel.: 06221-560
Medizinische Biometrie
Medizinische Biometrie und Informatik

Towards Personalized Prevention and Treatment of Gallbladder Cancer

May 6th, 2017 - Heidelberg Center para América Latina, Santiago de Chile, Chile


Objectives of the Symposium


  • To present recent advances towards personalized prevention and treatment of gallbladder cancer to the scientific and clinical community 
  • To share and inventory international expertise in the field, and to incorporate interested scientists and clinicians 
  • To establish priority areas of research (clusters) in order to enhance scientific interaction among cooperation partners
  • To define future collaborative strategies and concretize them into joint grant proposals




Welcome Address

    • Flavio Salazar Onfray, Vice-Presidency of Research and Development, Universidad de Chile
    • Raúl Andrés Silva Prado, Dean of the Medical Faculty, Universidad Católica del Maule
    • Ricardo Armisén, Head of Research Center of Excellence for Precision Medicine, Pfizer


    Session I: Ongoing Research Activities on Gallbladder Cancer


    • Recent Project Achievements (Justo Lorenzo Bermejo, Statistical Genetics Group, Institute of Medical Biometry and Informatics, University of Heidelberg)
    • Key lecture: The Swedish National Registries - A Gold Mine for Epidemiological Research, also in Gallbladder Cancer (Tahereh Moradi, Karolinska Institutet, Stockholm, Sweden)


    Coffee break (11:00-11:30)




    Session II: Ongoing Research Activities on Gallbladder Cancer (Cont.)

      • Update on Environmental and Genetic Characteristics of Chilean Gallbladder Cancer Patients and Families (Pablo Baez Benavides, School of Medicine, Universidad de Chile)
      • Recent Advances in the Molecular Diagnosis of Gallbladder Cancer (Gerardo Arroyo, Latin-American Gastrointestinal Oncology Intergroup, Argentina)
      • Current research on hepatobiliary cancer in Latin America (Bettina Müller, Chilean Cooperative Group for Oncologic Research)


        Lunch break (13:00-14:00)




        Session III: Next Steps and Group Meetings

          • Separate Meetings of the Pathology and Oncology Working Groups
          • Roundtable:  Main Conclusions from the Pathology and Oncology Working Groups
          • Incorporation of Interested Scientists and Clinicians from Chile and other South American Countries 
          • Open Questions, Next Symposium and Closing Remarks




            Select languageSelect language
            Print Diese Seite per E-Mail weiterempfehlen